We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+44.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.35B
AUM Growth
+$376M
(+38%)
Cap. Flow
+$77.8M
Cap. Flow
% of AUM
5.75%
Top 10 Holdings %
Top 10 Hldgs %
52.62%
Holding
81
New
21
Increased
33
Reduced
5
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$26.6M |
| 2 |
Arrowhead Research
ARWR
|
+$26.5M |
| 3 |
Prothena Corp
PRTA
|
+$24.3M |
| 4 |
Halozyme
HALO
|
+$23.9M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$134M |
| 2 |
AMRN
Amarin Corp
AMRN
|
+$9.41M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$9.22M |
| 4 |
KORU Medical Systems
KRMD
|
+$7.76M |
| 5 |
CareDx
CDNA
|
+$5.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.3% |
| 2 | Communication Services | 3.46% |
| 3 | Energy | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Codexis
CDXS
$151M
| $21M | 1.55% |
962,591
-27,867
| -3% | -$459K |
|
27
SI-BONE Inc
SIBN
$788M
| $20.2M | 1.49% |
673,982
+4,862
| +0.7% | +$118K |
|
28
Sutro Biopharma
STRO
$401M
| $18M | 1.33% |
+82,710
| New | +$13.7M |
|
|
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $14M | 1.03% |
137,400
+9,200
| +7% | +$852K |
|
30
QuidelOrtho
QDEL
$1.14B
| $11.6M | 0.86% |
64,686
+7,958
| +14% | +$1.77M |
|
31
OrthoPediatrics
KIDS
$519M
| $11.6M | 0.86% |
280,477
+56,435
| +25% | +$2.59M |
|
32
Maravai LifeSciences
MRVI
$969M
| $10.3M | 0.76% |
+368,200
| New | +$10.3M |
|
33
Ionis Pharmaceuticals
IONS
$8.6B
| $10.2M | 0.75% |
+179,601
| New | +$8.95M |
|
|
LITS
34
Lite Strategy Inc
LITS
$32.8M
| $10M | 0.74% |
189,664
+1,474
| +0.8% | +$85K |
|
35
Zymeworks
ZYME
$1.61B
| $9.34M | 0.69% |
197,702
+2,735
| +1% | +$127K |
|
36
Jazz Pharmaceuticals
JAZZ
$15.9B
| $8.58M | 0.63% |
51,962
+796
| +2% | +$119K |
|
|
TPTX
37
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.79M | 0.5% |
55,681
+848
| +2% | +$92.9K |
|
38
Simulations Plus
SLP
$369M
| $5.16M | 0.38% |
71,719
+888
| +1% | +$58.9K |
|
|
VAPO
39
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $5.1M | 0.38% |
23,733
+165
| +0.7% | +$36.8K |
|
40
The Joint Corp
JYNT
$118M
| $5.1M | 0.38% |
+194,105
| New | +$4.44M |
|
41
908 Devices
MASS
$329M
| $4.56M | 0.34% |
+80,000
| New | +$4.67M |
|
42
BioXcel Therapeutics
BTAI
$24.9M
| $4.35M | 0.32% |
+5,888
| New | +$4.59M |
|
|
APTO
43
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.68M | 0.27% |
+1,865
| New | +$4.38M |
|
|
LHCG
44
DELISTED
LHC Group LLC
LHCG
| $3.13M | 0.23% |
14,679
+222
| +2% | +$47.3K |
|
45
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
| $2.94M | 0.22% |
51,855
| – | – |
|
46
iShares Biotechnology ETF
IBB
$9.34B
| $2.53M | 0.19% |
16,713
| – | – |
|
47
iShares US Medical Devices ETF
IHI
$3.13B
| $2.48M | 0.18% |
45,480
| – | – |
|
48
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $2.07M | 0.15% |
18,241
| – | – |
|
49
Alphatec Holdings
ATEC
$1.46B
| $1.92M | 0.14% |
+132,500
| New | +$1.4M |
|
|
ALXN
50
DELISTED
Alexion Pharmaceuticals
ALXN
| $969K | 0.07% |
+6,200
| New | +$797K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, First Light Asset Management held 81 positions worth $1.35B, up 38% from $976M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Light Asset Management deployed $77.8M of net new capital in Q4 2020, opening 21 new positions and adding to 33 existing holdings. Its largest new stake was Prothena Corp: 2,056,453 shares worth $24.7M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 72% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was KORU Medical Systems, an estimated $7.76M trimmed.
- First Light Asset Management's largest Q4 2020 buy was Prothena Corp: 2,056,453 shares worth $24.7M.
- First Light Asset Management added most to Health Catalyst in Q4 2020, an estimated $26.6M increase.
- First Light Asset Management's biggest Q4 2020 reduction was KORU Medical Systems, cutting an estimated $7.76M.
- First Light Asset Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $134M.
- First Light Asset Management's ten largest holdings make up 53% of its $1.35B portfolio in Q4 2020.
- First Light Asset Management opened 21 new positions and closed 7 in Q4 2020.
- First Light Asset Management's portfolio value rose 38% quarter-over-quarter to $1.35B.
Based on First Light Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.